Mariner
FATE icon

Mariner’s Fate Therapeutics FATE Stock Holding History

Mariner’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519K Buy
192,215
+93,920
+96% +$174K ﹤0.01% 2432
2026
Q1 		$118K Buy
98,295
+83,406
+560% +$102K ﹤0.01% 3292
2025
Q4 		$14.6K Sell
14,889
-8,041
-35% -$9.66K ﹤0.01% 3503
2025
Q3 		$28.9K Buy
22,930
+11,393
+99% +$12.3K ﹤0.01% 3491
2025
Q2 		$12.9K Buy
+11,537
New +$13.4K ﹤0.01% 3446

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mariner's FATE Position: Q2 2026 in Review

Mariner increased its Fate Therapeutics (FATE) stake by 96% in Q2 2026, buying an estimated $174K and bringing the position to 192,215 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #2432.

Mariner first reported a position in FATE in Q2 2025 and has held it in 5 quarters since. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Mariner held 192,215 shares of Fate Therapeutics worth $519K as of Q2 2026.
  • Mariner bought 93,920 Fate Therapeutics shares in Q2 2026, an estimated $174K.
  • Fate Therapeutics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2432 holding.
  • Mariner first reported a position in Fate Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.